Nuclear magnetic resonance-based metabolomics and metabolic pathway networks from patient-matched esophageal carcinoma, adjacent noncancerous tissues and urine

Figure 5 Altered metabolic pathways for the most relevant distinguishing metabolites (potential biomarkers) in urine and tissue samples between esophageal cancer patients and healthy controls. Red text: Increased with respect to control in both esophageal cancer (EC) patient tissue and urine; pink text: Increased with respect to control in EC tissue; orange text: Increased with respect to control in EC patient urine; purple text: Decreased with respect to control in both EC patient tissue and urine; blue text: Decreased with respect to control in EC tissue; green text: Decreased with respect to control in EC patient urine.